Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk

Area of Science:

• Genetics and Genomics
• Cancer Research
• Mitochondrial Biology

Background:

• Mitochondrial metabolism is implicated in pancreatic ductal adenocarcinoma (PDAC) risk.
• Genetic variations in mitochondrial function may influence PDAC etiology.
• Previous systematic investigations of mitochondrial genome (mtSNPs) and nuclear genes (n-mtSNPs) in PDAC risk are lacking.

Purpose of the Study:

• To systematically investigate the association of mitochondrial single nucleotide polymorphisms (mtSNPs) and nuclear genetic variations affecting mitochondrial function (n-mtSNPs) with PDAC risk.
• To assess the impact of genetic variability in mitochondrial metabolism on PDAC susceptibility.

Main Methods:

• A two-phase association study analyzing 35,297 n-mtSNPs and 101 mtSNPs in up to 55,870 individuals (12,884 PDAC cases, 42,986 controls).
• Utilized Multi-marker Analysis of GenoMic Annotation (MAGMA) for gene-level analysis of 1,588 genes involved in mitochondrial metabolism.

Main Results:

• The discovery phase identified 49 n-mtSNPs associated with PDAC risk (P < 0.05), but these findings were not replicated in the second phase.
• No significant association was found for mtSNPs in either phase.
• Gene-level analysis revealed potential associations for TERT, SUGCT, and SURF1 below the Bonferroni-corrected significance threshold.

Conclusions:

• This large-scale study demonstrates that neither nuclear genetic variations affecting mitochondrial function (n-mtSNPs) nor mitochondrial genome variations (mtSNPs) are significantly associated with PDAC risk.
• The findings do not support a role for genetic variability in mitochondrial function in the etiology of pancreatic ductal adenocarcinoma.
• Despite the potential involvement of mitochondrial metabolism in PDAC, specific genetic variations studied do not appear to be risk factors.